Mining the human gut microbiome for novel stress resistance genes

Gut Microbes

Volumn 3, Issue 4, 2012, Pages

  Culligan, Eamonn P ^a,b   Marchesi, Julian R ^a,d   Hill, Colin ^a,b   Sleator, Roy D ^c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c Munster Technological University   (Ireland)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Functional metagenomics; Human gut microbiome; Meta biotechnology; Salt tolerance

Indexed keywords

ARTICLE; BIOINFORMATICS; FUNCTIONAL STATUS; GENE IDENTIFICATION; GENE LOCUS; HUMAN; INTESTINE FLORA; METAGENOMICS; MICROBIOME; MICROENVIRONMENT; NONHUMAN; SALT TOLERANCE; STRESS;

EID: 84863871327     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Sleator RD, Hill C. Engineered pharmabiotics with improved therapeutic potential. Hum Vaccin 2008; 4:271-4; PMID:18682694; http://dx.doi. org/10.4161/hv.4.4.6315.
2. Sleator RD, Hill C. New frontiers in probiotic research. Lett Appl Microbiol 2008; 46:143-7; PMID:18028323; http://dx.doi.org/10.1111/j.1472-765X.2007.02293.x.
3. Louis P, O'Byrne CP. Life in the gut: microbial responses to stress in the gastrointestinal tract. Sci Prog 2010; 93:7-36; PMID:20222354; http://dx.doi. org/10.3184/003685009X12605525292307.
4. Sleator RD, Hill C. Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence. FEMS Microbiol Rev 2002; 26:49-71; PMID:12007642; ht tp: //dx. doi.org/10.1111/j.1574-6976.2002. tb00598.x.
5. Epstein W. The roles and regulation of potassium in bacteria. Prog Nucleic Acid Res Mol Biol 2003; 75:293-320; PMID:14604015; http://dx.doi. org/10.1016/S0079-6603(03)75008-9.
6. Kempf B, Bremer E. Uptake and synthesis of compatible solutes as microbial stress responses to high-osmolality environments. Arch Microbiol 1998; 170:319-30; PMID:9818351; http://dx.doi. org/10.1007/s002030050649.
7. Piuri M, Sanchez-Rivas C, Ruzal SM. Adaptation to high salt in Lactobacillus: role of peptides and proteolytic enzymes. J Appl Microbiol 2003; 95:372-9; PMID:12859771; http://dx.doi.org/10.1046/j.1365-2672.2003.01971.x.
8. Sleator RD, Hill C. A novel role for the LisRK two-component regulatory system in listerialosmotolerance. Clin Microbiol Infect 2005; 11:599-601; PMID:16008610; http://dx.doi.org/10.1111/j.1469-0691.2005.01176.x.
9. Sleator RD, Shortall C, Hill C. Metagenomics. Lett Appl Microbiol 2008; 47:361-6; PMID:19146522; http://dx.doi.org/10.1111/j.1472-765X.2008.02444.x.
10. Sleator RD. The human superorganism-of microbes and men. Med Hypotheses 2010; 74:214-5.
11. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, et al. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci USA 2011; 108:6252-7; PMID:21436049; http:// dx.doi.org/10.1073/pnas.1102938108.
12. Culligan EP, Sleator RD, Marchesi JR, Hill C. Functional metagenomics reveals novel salt tolerance loci from the human gut microbiome. ISME J 2012; In press; PMID:22534607; http://dx.doi. org/10.1038/ismej.2012.38.
13. Shabala L, Bowman J, Brown J, Ross T, McMeekin T, Shabala S. Ion transport and osmotic adjustment in Escherichia coli in response to ionic and nonionic osmotica. Environ Micro boil 2009; 11:137-48; PMID:18793315; http://dx.doi.org/10.1111/j.1462-2920.2008.01748.x.
14. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/ nature08821.
15. Böhringer J, Fischer D, Mosler G, Hengge-Aronis R. UDP-glucose is a potential intracellular signal molecule in the control of expression of sigma S and sigma S-dependent genes in Escherichia coli. J Bacteriol 1995; 177:413-22; PMID:7814331.
16. Leloir LF. The enzymatic transformation of uridinediphosphate glucose into a galactose derivative. Arch Biochem Biophys 1951; 33:186-90; PMID:14885999; http://dx.doi.org/10.1016/0003-9861(51)90096-3.
17. Mori T, Suenaga H, Miyazaki K. A metagenomic approach to the identification of UDP-glucose 4-epimerase as a menadione resistance protein. Biosci Biotechnol Biochem 2008; 72:1611-4; PMID:18540088; http://dx.doi.org/10.1271/ bbb.70815.
18. Conly JM, Stein K. Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol 1992; 87:311-6; PMID:1539565.
19. Macfarlane S, Dillon JF. Microbial biofilms in the human gastrointestinal tract. J Appl Microbiol 2007; 102:1187-96; PMID:17448154; http://dx.doi. org/10.1111/j.1365-2672.2007.03287.x.
20. Ho TD, Waldor MK. Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization. Infect Immun 2007; 75:1661-6; PMID:17158899; http://dx.doi.org/10.1128/IAI.01342-06.
21. Nakao R, Senpuku H, Watanabe H. PorphyromonasgingivalisgalE is involved in lipopolysaccharide O-antigen synthesis and biofilm formation. Infect Immun 2006; 74:6145-53; PMID:16954395; http://dx.doi.org/10.1128/ IAI.00261-06.
22. vanHeijenoort J. Murein synthesis. In: Neidhardt FC, Curtis R, III, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaecter M, Umbarger HE, Ed. Escherichia coli and Salmonella: cellular and molecular biology. Washington DC: American Society for Microbiology 1996; 1025-34.
23. Vijaranakul U, Nadakavukaren MJ, de Jonge BL, Wilkinson BJ, Jayaswal RK. Increased cell size and shortened peptidoglycan interpeptide bridge of NaCl-stressed Staphylococcus aureus and their reversal by glycine betaine. J Bacteriol 1995; 177:5116-21; PMID:7665491.
24. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16:228-31; PMID:20081863; http://dx.doi.org/10.1038/nm.2087.
25. Galperin MY, Moroz OV, Wilson KS, Murzin AG. House cleaning, a part of good housekeeping. Mol Microbiol 2006; 59:5-19; PMID:16359314; http:// dx.doi.org/10.1111/j.1365-2958.2005.04950.x.
26. Lu LD, Sun Q, Fan XY, Zhong Y, Yao YF, Zhao GP. Mycobacterial MazG is a novel NTP pyrophosphohydrolase involved in oxidative stress response. J BiolChem 2010; 285:28076-85; PMID:20529853; http://dx.doi.org/10.1074/jbc.M109.088872.
27. Gross M, Marianovsky I, Glaser G. MazG-a regulator of programmed cell death in Escherichia coli. Mol Microbiol 2006; 59:590-601; PMID:16390452; http://dx.doi.org/10.1111/j.1365-2958.2005.04956.x.
28. Hazan R, Sat B, Engelberg-Kulka H. Escherichia coli mazEF-mediated cell death is triggered by various stressful conditions. J Bacteriol 2004; 186:3663-9; PMID:15150257; http://dx.doi.org/10.1128/ JB.186.11.3663-9.2004.
29. Wang X, Wood TK. Toxin-antitoxin systems influence biofilm and persister cell formation and the general stress response. Appl Environ Microbiol 2011; 77:5577-83; PMID:21685157; http://dx.doi. org/10.1128/AEM.05068-11.
30. Yamaguchi Y, Park JH, Inouye M. Toxin-antitoxin systems in bacteria and archaea. Annu Rev Genet 2011; 45:61-79; PMID:22060041; http://dx.doi. org/10.1146/annurev-genet-110410-132412.
31. Erental A, Sharon I, Engelberg-Kulka H. Two programmed cell death systems in Escherichia coli: an apoptotic-like death is inhibited by the mazEF-mediated death pathway. PLoS Biol 2012; 10:1001281; PMID:22412352; http://dx.doi.org/10.1371/journal. pbio.1001281.
32. Sleator RD. Probiotic therapy-recruiting old friends to fight new foes. Gut Pathog 2010; 2:5; PMID:20579345; http://dx.doi.org/10.1186/1757-4749-2-5.
33. Sleator RD. Probiotics-a viable therapeutic alternative for enteric infections especially in the developing world. Discov Med 2010; 10:119-24; PMID:20807472.
34. Shapiro AB, Livchak S, Gao N, Whiteaker J, Thresher J, Jahic H, et al. A homogeneous, highthroughput-compatible, fluorescence intensity-based assay for UDP-N-acetylenolpyruvylglucosaminered uctase (MurB) with nanomolar product detection. J Biomol Screen 2012; 17:327-38; PMID:22068704; http://dx.doi.org/10.1177/1087057111425188.
35. Urbaniak MD, Tabudravu JN, Msaki A, Matera KM, Brenk R, Jaspars M, et al. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness. Bioorg Med Chem Lett 2006; 16:5744-7; PMID:16962325; http://dx.doi.org/10.1016/j.bmcl.2006.08.091.
36. Germanier R, Füer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis 1975; 131:553-8; PMID:1092768; http://dx.doi. org/10.1093/infdis/131.5.553.
37. Engelberg-Kulka H, Sat B, Reches M, Amitai S, Hazan R. Bacterial programmed cell death systems as targets for antibiotics. Trends Microbiol 2004; 12:66-71; PMID:15036322; http://dx.doi. org/10.1016/j.tim.2003.12.008.
38. Culligan EP, Hill C, Sleator RD. Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathog 2009; 1:19; PMID:19930635; http://dx.doi.org/10.1186/1757-4749-1-19.
39. Sleator RD, Hill C. Patho-biotechnology: using bad bugs to do good things. Curr Opin Biotechnol 2006; 17:211-6; PMID:16459072; http://dx.doi. org/10.1016/j.copbio.2006.01.006.
40. Sleator RD, Hill C. Patho-biotechnology; using bad bugs to make good bugs better. Sci Prog 2007; 90:1-14; PMID:17455762; http://dx.doi. org/10.3184/003685007780440530.
41. Sheehan VM, Sleator RD, Hill C, Fitzgerald GF. Improving gastric transit, gastrointestinal persistence and therapeutic efficacy of the probiotic strain Bifidobacteriumbreve UCC2003. Microbiology 2007; 153:3563-71; PMID:17906153; http://dx.doi. org/10.1099/mic.0.2007/006510-0.
42. Focareta A, Paton JC, Morona R, Cook J, Paton AW. A recombinant probiotic for treatment and prevention of cholera. Gastroenterology 2006; 130:1688-95; PMID:16697733; http://dx.doi.org/10.1053/j. gastro.2006.02.005.